Evidence map›Paper›PMID 40811433›Full record

ArticlePLoS biology2025

Archaea produce peptidoglycan hydrolases that kill bacteria.

Romain Strock, Valerie W C Soo, Pauline Misson, Georgia Roumelioti, Pavel V Shliaha, Antoine Hocher, Tobias Warnecke

Abstract read
In one paragraph

Article in PLoS biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Romain StrockMedical Research Council Laboratory of Medical Sciences, London, United Kingdom.
Valerie W C SooMedical Research Council Laboratory of Medical Sciences, London, United Kingdom.
Pauline MissonMedical Research Council Laboratory of Medical Sciences, London, United Kingdom.
Georgia RoumeliotiMedical Research Council Laboratory of Medical Sciences, London, United Kingdom.
Pavel V ShliahaMedical Research Council Laboratory of Medical Sciences, London, United Kingdom.
Antoine HocherMedical Research Council Laboratory of Medical Sciences, London, United Kingdom.
Tobias WarneckeMedical Research Council Laboratory of Medical Sciences, London, United Kingdom.ORCID 0000-0002-4936-5428

Funding

Wellcome Trust
6 · The paper itself

Abstract

The social life of archaea is poorly understood. In particular, even though competition and conflict are common themes in microbial communities, there is scant evidence documenting antagonistic interactions between archaea and their abundant prokaryotic brethren: bacteria. Do archaea specifically target bacteria for destruction? If so, what molecular weaponry do they use? Here, we present an approach to infer antagonistic interactions between archaea and bacteria from genome sequence. We show that a large and diverse set of archaea encode peptidoglycan hydrolases, enzymes that recognize and cleave a structure-peptidoglycan-that is a ubiquitous component of bacterial cell walls but absent from archaea. We predict the bacterial targets of archaeal peptidoglycan hydrolases using a structural homology approach and demonstrate that the predicted target bacteria tend to inhabit a similar niche to the archaeal producer, indicative of ecologically relevant interactions. Using a heterologous expression system, we demonstrate that two peptidoglycan hydrolases from the halophilic archaeaon Halogranum salarium B-1 kill the halophilic bacterium Halalkalibacterium halodurans, a predicted target, and do so in a manner consistent with peptidoglycan hydrolase activity. Our results suggest that, even though the tools and rules of engagement remain largely unknown, archaeal-bacterial conflicts are likely common, and we present a roadmap for the discovery of additional antagonistic interactions between these two domains of life. Our work has implications for understanding mixed microbial communities that include archaea and suggests that archaea might represent a large untapped reservoir of novel antibacterials.

Indexed as

ArchaeaBacteriaN-Acetylmuramoyl-L-alanine AmidaseCell WallPeptidoglycanPhylogenyN-Acetylmuramoyl-L-alanine AmidasePeptidoglycan

Identifiers

PMID40811433
PMCPMC12352652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.